A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular carcinoma (HCC) patien...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Mol Hepatol
Autori principali: Yang, Hyun, Woo, Hyun Young, Lee, Soon Kyu, Han, Ji Won, Jang, Bohyun, Nam, Hee Chul, Lee, Hae Lim, Lee, Sung Won, Song, Do Seon, Song, Myeong Jun, Oh, Jung Suk, Chun, Ho Jong, Jang, Jeong Won, Lozada, Angelo, Bae, Si Hyun, Choi, Jong Young, Yoon, Seung Kew
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Association for the Study of the Liver 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497665/
https://ncbi.nlm.nih.gov/pubmed/28494528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0071
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi